We have audited the invitation for uptake and outcome of artificial reproductive techniques in patients undergoing SCT for haematological malignancy, with the aim of improving our pre-transplant counselling. A postal survey was sent to 434 patients in our centre surviving a minimum of 2 years after allo-SCT, of whom 221 patients responded. Of 112 male patients, 79 were offered sperm storage, 42 banked sperm and 25 subsequently attempted parenthood with stored sperm. A total of 18 were successful, with 29 children born a median of 8 years (range 1-22 years) following SCT. Of 72 females o42 years old, 33 were offered storage of embryos/eggs/ ovarian tissue and 12 accepted. Following SCT, four women attempted pregnancy using cryopreserved embryos, with two successes. The majority of patients who were not counselled about infertility or not offered fertility-preservation options provided a likely reason, with completion of family being the most frequent. Nonetheless, 16 patients (11/72 women and 5/112 men) could not provide a reason for the lack of information/ invitation. In conclusion, uptake of gamete/embryo storage is high when offered and collected material is used frequently. Pregnancies in partners of male patients were usually successful and our data highlight the value of prolonged cryostorage.
Introduction
As life expectancy following SCT improves, there is wider recognition of the problems associated with survivorship and infertility is one such issue. 1, 2 Following pre-transplant conditioning with regimens that include TBI or BU, premature ovarian failure is the norm. 3 In male patients these agents can be associated with impaired sertoli cell function and azoospermia. Although recovery of gametogenesis can occur, such events are unusual. 4 Infertility from any cause can result in significant unresolved grief and depression, and the experience of cancer may further increase the value placed on parenthood. 5 Since the birth of the first 'test tube' baby over 30 years ago, reproductive medicine has offered hope to patients who face treatment-induced gonadal failure. 6, 7 In 2004, a fertility management guideline published by the National Institute for Health and Clinical Excellence stated that there should be universal access to sperm, egg and embryo storage for patients undergoing gonadotoxic treatment. 8 This document was followed in 2007 by guidance on management of the effects of cancer treatment on reproductive function by a joint Royal College working party. 9 This guideline also recommended that male patients with reproductive potential requiring anti-cancer treatment should be routinely offered sperm banking and female patients should be offered embryo storage where there is a partner and sufficient time for egg harvesting.
In this study we have audited the number of patients invited to store gametes/embryos/tissue for use after SCT and explored reasons why the invitation may not have occurred. We have also audited the uptake and outcome of using stored gametes/embryos after SCT, with a view to improving our pre-transplant counselling and informing local service delivery.
Patients and methods
A questionnaire was sent to all 434 patients (178 female) in our centre, surviving a minimum of 2 years after allogeneic SCT for haematological malignancy as of May 2009. Patients who did not wish to participate were asked to return a blank questionnaire so that non-involvement could be recorded. The questionnaire included items on:
1. Pre-treatment counselling about infertility 2. Uptake of gamete storage (men and women), ovarian tissue or embryos (women) 3. Patient perceptions of why infertility or gamete/embryo storage was not discussed 4. Use of stored tissue 5. Outcome of using stored tissue 6. Reasons why patients chose not to store gametes/ embryos or tissue
The study was exempted from formal ethical approval, because it was classified as an audit of clinical activity with a service delivery component.
Results
Of the 434 questionnaires sent, 221 (51%) patients responded and 9 indicated that they did not wish to participate further. Characteristics of the 212 participants are summarised in Table 1 . The median transplant-follow-up time was 11 years (range 2-29), with the year of transplant spanning from 1979 to 2007.
Gamete storage in male patients
Of 112 male patients, 79 were invited to store sperm before SCT, of whom 42 proceeded to do so. Of those who were not invited to do so (n ¼ 33), it was notable that 11 did not recall being counselled about likely infertility after treatment. Nonetheless, the majority (28/33) of these patients perceived the lack of counselling/lack of invitation to bank sperm to have been appropriate (Figure 1 ). The main reason for not storing sperm or not being invited to do so was older age or an expressed desire not to have further children. Other reasons given were lack of time due to medical urgency, lack of facilities (non UK resident) and insufficient understanding at the time. A total of 11 patients did not proceed to storage because of non-viability of sperm (confirmed in 7 cases and assumed owing to previous exposure to chemotherapy in 4 cases). Of the 11 patients who did not remember being counselled about infertility, only 4 could not think of a reason why; 3 had completed their family, 3 cases required urgent treatment and another patient was too young.
Use of stored gametes in male patients
Partners of 25/42 men who had banked sperm subsequently attempted pregnancy and 18 were successful ( Table 2) . Three of these women had two successful pregnancies each. The median age of male patients at the time of use was 29 years (range 21-42), a median of 8 years post transplant (range 2-25 years). Out of 21, 12 pregnancy attempts occurred 5 years or more after transplant and 6/21 occurred 10 years or more after SCT. The median number of attempts for successful patients was 2 (range 1-10), with 9/21 pregnancies conceived on the first attempt. At least 
Yes (n=42) Figure 1 Primary reasons for non-uptake of gamete storage in men. Uptake and outcome of ART in SCT survivors A Babb et al 15 successful pregnancies occurred through the use of intracytoplasmic sperm injection, 8 of which were twin pregnancies ( Table 2) . Four men attempted a second pregnancy, which was successful in three cases (one, four and six attempts). Seven patients were unsuccessful, with a median number of attempts of 2 (range 1-4). The number of attempts per successful pregnancy was 3.44 with a delivery rate per cycle of 29%.
Three additional patients volunteered that they had parented children using donated sperm. One further patient who had received a CY/TBI conditioned unrelated donor transplant conceived a daughter naturally 8 years post transplant. This is a rare occurrence that has been previously described. 10 Gamete storage in female patients Of the 100 responding female patients, 72 were under the age of 42, which was pragmatically selected as the upper limit of a reproductive age group (Figure 2) . Out of these, 33 were offered storage of embryos/eggs/ovarian tissue, of whom 12 proceeded to do so. Eight women had stored embryos, four had stored oocytes and two had stored ovarian tissue; this included two women who had stored ooctyes in addition to either embryos or ovarian tissue. Of 72 women, 39 were not offered intervention that would assist artificial reproduction after SCT: 18/72 women did not recall being counselled about infertility and 21 women were warned about infertility but not offered intervention. Of these 39 women, 15 had completed their family and 8 felt that medical urgency underlay the lack of discussion/invitation. Eight women in this age group could give no reason why infertility was not discussed and three women with whom infertility was discussed gave no indication as to why they were not offered the storage of embryos/ovarian tissue. Although 7/72 (10%) women in a potentially reproductive age group could give no reason for their lack of counselling, it is notable that the number of patients who recalled being counselled increased in a stepwise fashion to 490%, when patient data were stratified according to the year of transplant ( Table 3 ), suggesting that physician awareness or availability of techniques may have been relevant.
Seven women with CML were offered the option of delaying their transplant so that they could have children naturally first; this option was taken up by two.
Use of stored/donated gametes in female patients
Five of eight women with stored embryos (62%) used them following transplantation. One patient used her stored embryos to attempt pregnancy in a surrogate mother, but this was unsuccessful. A further four patients attempted pregnancy themselves using their own stored embryos. The pregnancy rate per cycle among these 4 women was 4/7 (57%), with 3 women conceiving 4 pregnancies post transplant. Two of these pregnancies miscarried in the first trimester, giving a live birth rate per cycle of 2/7 (29%). Successful pregnancies occurred 3 and 7 years post transplant in women aged 34 and 41 years, respectively. Although neither of these latter patients had been taking hydroxycarbamide at the time of egg collection, both of these women had received hydroxycarbamide in the months preceding egg collection; one receiving a total of 2 months of treatment and the other 6 months. Of the four patients who attempted pregnancy with stored embryos, two had chronic GVHD. Neither of these women had a successful pregnancy; one of these patients conceived on her third attempt but miscarried at 12 weeks.
An additional patient who had not stored embryos before SCT had two successful pregnancies with donor eggs fertilized with her partner's sperm. Delivery of healthy infants occurred 14 and 16 years after SCT, when she was 36 and 38 years old, respectively. 
No n =28 (21)
Yes n =12(12) Figure 2 Primary reasons for non-uptake of gamete storage in women (numbers in italics for women less than 42 years at stem cell transplant).
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Discussion
The majority of patients participating in this study recalled being counselled about infertility before potentially sterilizing treatment was administered. This increased from rates of 42% before 1990 to 86% for transplants after this time. In all, 79 out of 112 male patients were offered sperm banking and it was taken up by 42 men. Also, 33 of 72 females in a reproductive age group were offered embryo/gamete or tissue storage and this was taken up by 12 women. Most of the patients who were not counselled about infertility or who were not offered gamete/embryo storage had already completed their families or else had insufficient time to arrange storage before proceeding with treatment. A minority of patients, comprising 5/112 (4%) men and 11/72 (15%) women, gave no reason for the lack of information/invitation. In all 60% of men with banked sperm and 62% of women with cryopreserved embryos had used stored material to attempt parenthood, when assessed a median of 11 years after transplant. The majority of men who used stored sperm (72%) had a successful outcome. Five women used their stored embryos after transplantation, two of whom (40%) had live births following SCT.
Rates of counselling and sperm banking in our centre compared well with other questionnaire-based studies. In a study of male patients aged 14-40 undergoing cancer treatment in the USA, 11 only 60% recalled being counselled about infertility, 51% were offered sperm banking and 24% stored sperm. 9 In the latter study, the main reason for patients not banking was lack of information. A second study by the same group explored physician attitudes 12 and found that although 91% oncologists agreed that sperm banking should be offered to all eligible men, in practice 48% offered it less than 25% of the time. The most commonly given reasons for not offering sperm cryopreservation were difficulty in finding sperm banks, financial implications for the patient or insufficient time. A recent UK-based study of haematology and oncology consultants suggests that deficiencies in physician training may be relevant, with 21% respondents being unaware of local policies on sperm banking. 13 Several factors are likely to have contributed to the high invitation and uptake of sperm storage in this centre. First, the andrology unit is on the same site as the transplant unit, facilitating referral, counselling and gamete collection. Second, although fertility treatment is not universally funded by the National Health Service, cost implications for sperm storage in UK patients receiving SCT in this centre have hitherto been minimal. Third, our clinical practice is dominated by patients with CML, and if in chronic phase it is frequently possible to delay treatment to give time for counselling and sperm collection. Finally, our study was conducted in a single centre, which is highly protocol-led and in which infertility is expected in the majority of patients; these factors facilitate a uniform approach to staff training and pre-transplant counselling.
Rates of counselling for women also compared favourably with other studies. 12, 14 Nonetheless, 18 women of reproductive age in our study were not counselled about infertility and a further 21 patients were warned about infertility but not offered intervention to assist pregnancy after the transplant. Although many of these patients provided a reason why counselling/intervention may have been unnecessary, a substantially higher percentage of women (15%) compared with male patients (4%) were unable to provide a reason for the lack of information/ invitation. Part of the reason for this may have been lack of awareness among the medical staff about the techniques available for artificial reproductive techniques (ART) in women. Another possibility is that physicians could have made assumptions about female patients' interest in pursuing ART that influenced their consultations. A study by Gilbert et al. 11 highlighted that physicians make variable assumptions about patient needs in relation to parenthood based on patient factors, such as age and the physician's own moral conclusions. For example, 7.6% of the physicians would tend not to offer sperm banking to a patient of 40 years of age or older, whereas 35.8% would use a cut-off of 50 years or older; 3% would not offer it to someone who already had a child. It is possible that physicians' assumptions of this type had a role in offering ART to the patients in this study and that such factors were stronger in relation to female patients, because of the degree of intervention required for ART in women compared with men.
Only half of the female patients invited to store embryos or gametes proceeded to do so. Some had completed their families, but of those who had not, the most common reason for not being offered or proceeding with storage was felt to be medical urgency, or else technology being unavailable. These data reflect the greater degree of intervention and time delays required for egg retrieval compared with sperm collection. Notably, lack of availability of ART techniques was a limitation cited by patients undergoing transplant in 1979, 1983 and 1991, whereas Table 4 Outcome for assisted reproductive techniques using cryopreserved semen from cancer patients The proportion of men in this study who proceeded to use sperm to attempt pregnancy was high (at 60%) compared with other studies of oncology patients where the rates range between 1.3-9.7%. This may reflect the natural recovery of spermatogenesis after other cancer treatments and shorter follow-up times. In this study, sperm was used to attempt pregnancy a median of 8 years post SCT, with a wide range extending to 22 years. Given this range and since the median assessment is only 3 years after the median attempt time, it might be expected that the proportion of patients eventually wanting to use frozen sperm will increase even further. One-third of the patients using stored sperm did so after more than 10 years of storage, highlighting the value of prolonged sperm storage for this group of patients.
The pregnancy success rate using stored sperm was high in our study, with 72% of men conceiving successful pregnancies, giving one live birth rate per 3.4 cycles. These data are more successful than those quoted in other studies involving men treated for cancer (Table 4) . [15] [16] [17] [18] [19] However, most of the latter were reported around 10 years before the current study and our data are likely to reflect improvements in reproductive techniques over the last decade.
Of the four female patients attempting pregnancy with their own frozen embryos, the live birth rate per transfer was 29%. The age range of these women at the time of ART was 34-41years. Data from the Human Fertilisation and Embryo Authority for non-transplant populations give a live birth rate per cycle of 17.9% for women less than 35 years, which falls to 10% for women over 42 years. 20 Although there are theoretical concerns that the effects of radiation on the uterus or cGVHD could reduce the chance of successful pregnancy following ART, 21, 22 there was no evidence for this in the current study.
Several questions regarding in vitro fertilization in this setting remain unanswered: for example, the possible impact of preceding hydroxycarbamide or of chronic GVHD on success rates. It is notable, therefore, that two successful pregnancies occurred to women whose eggs were collected after instigation of hydroxycarbamide. Both successful pregnancies occurred in women who did not have evidence of chronic GVHD; however, it is difficult to draw any conclusions from this, because the numbers are small.
In summary, our data demonstrate a high incidence of uptake of gamete/embryo storage when it is offered to the patient and highlights a need for prolonged cryostorage in some circumstances. After transplant, collected material is used frequently. Pregnancies in partners of male patients were often successful and there was no evidence that the success rate of ART in female recipients of SCT was inferior to that of non-transplant populations. Ongoing physician education will be necessary to maintain and further improve the pretransplant counselling process and maximize invitations to store gametes and embryos in line with current national guidelines.
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